Primary juxtaarticular soft tissue lymphoma arising in the vicinity of inflamed joints in patients with rheumatoid arthritis

Citation
Jr. Goodlad et al., Primary juxtaarticular soft tissue lymphoma arising in the vicinity of inflamed joints in patients with rheumatoid arthritis, HISTOPATHOL, 34(3), 1999, pp. 199-204
Citations number
29
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
HISTOPATHOLOGY
ISSN journal
03090167 → ACNP
Volume
34
Issue
3
Year of publication
1999
Pages
199 - 204
Database
ISI
SICI code
0309-0167(199903)34:3<199:PJSTLA>2.0.ZU;2-#
Abstract
Aims: Primary soft tissue lymphoma is uncommon and little is known regardin g its aetiology and pathogenesis. In a review of 37 soft tissue lymphomas w e uncovered three cases associated with rheumatoid arthritis which we repor t herein. Methods and results: The clinical records and pathology of the cases are de scribed together with the results of in situ hybridization studies with oli gonucleotide probes to Epstein-Barr virus (EBV) encoded RNA (EBER), All thr ee patients were females with a long-standing history of rheumatoid arthrit is ranging from 9 to 17 years, Each presented with a soft tissue mass in th e vicinity of a joint affected by rheumatoid disease. All had received prio r treatment with nonsteroidal anti-inflammatory drugs and one also received gold, penicillamine and intra-articular steroids to affected joints. None had received methotrexate. Histologically, the juxtaarticular soft tissue m asses were all B-cell lymphomas. None were associated with EBV as determine d by in situ hybridization. Conclusions: These cases document an association between rheumatoid arthrit is and soft tissue lymphoma of B-cell type, arising in the vicinity of an a ffected joint. Chronic local immune stimulation may have played a significa nt role in the genesis of these lymphomas, unlike the frequently reversible and EBV-positive lymphomas that occur in rheumatoid patients on immunosupp ressive therapy.